Despite reasonably successful progress in clinical trials of its most advanced oral candidate danuglipron, the company halted development in April, owing to a possible drug-induced liver injury in one participant of an earlier study
Los medicamentos GLP-1 estn indicados para diabetes tipo 2 (no para diabetes tipo 1) con control glucmico inadecuado y obesidad (IMC 30 kg/m o 27 kg/m con comorbilidades), requiriendo prescripcin mdica
Advances in Nutrition , 12 (6), 2540-2552
Oral GLP-1 warnings You should not take Rybelsus if youve had an allergic reaction to Rybelsus, Ozempic, or Wegovy (the last two are injectable forms of semaglutide)
Estimulao do Sistema Imune: Reforando as defesas naturais do corpo, os probiticos desempenham um papel crucial na promoo da sade imunolgica
Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications